2024-11-07 - Analysis Report
## Danaher Corp (DHR) Stock Analysis Report

**Company Overview:** 
Danaher Corp is a global science and technology company that designs, manufactures, and markets a wide range of products and services for life sciences, diagnostics, dental, environmental, and industrial markets.

**Performance Summary:**
* **Rate of Return:** DHR has generated a cumulative return of 219.98% compared to 134.06% for the S&P 500 (VOO). This represents an outperformance of 85.92 points.  The relative outperformance is at the 39.29% percentile of historical data, indicating that it has outperformed the market by a significant margin but is not at its highest relative outperformance level.
* **Alpha and Beta Analysis:** DHR exhibits a strong alpha and relatively stable beta, demonstrating its ability to consistently outperform the market. 
    * **Alpha:**  DHR consistently shows positive alpha, highlighting its ability to generate returns above the benchmark.
    * **Beta:**  DHR's beta is mostly around 0.9, suggesting it is less volatile than the broader market, which can be a desirable characteristic for some investors.
* **Recent Price Action:**  DHR's recent price action suggests a potential slowdown, as it is trading below its 5-day, 20-day, and 60-day moving averages. 
    * **Close Price:** 247.96
    * **5-day Moving Average:** 246.6
    * **20-day Moving Average:** 258.36
    * **60-day Moving Average:** 266.69
* **Technical Indicators:**
    * **RSI:** 31.02, suggesting the stock is currently in oversold territory. 
    * **PPO:** -0.35, indicating potential weakness or selling pressure. 
    * **Relative Divergence:** -10.95, signaling a short-term downtrend in the stock's price. 
    * **Expected Return:** 83.19%, indicating a potential for significant long-term returns over the S&P 500. 
* **Recent Earnings:**  DHR has delivered consistent earnings growth, with revenue exceeding $5 Billion in recent quarters. 
    * **2024-10-22:** EPS = 1.13, Revenue = $5.80 B
    * **2024-07-23:** EPS = 1.23, Revenue = $5.74 B
    * **2024-04-23:** EPS = 1.47, Revenue = $5.80 B
    * **2024-02-21:** EPS = 1.46, Revenue = $6.41 B
    * **2023-10-24:** EPS = 1.53, Revenue = $5.62 B
* **Financial Data:**  DHR demonstrates strong profitability with high revenue and profit margins. The company also maintains a healthy capital structure with robust equity and return on equity. However, ROE has been declining in the last few quarters, which needs further examination.
* **News and Recent Issues:** Recent earnings reports for DHR were met with mixed reactions from analysts.  Some analysts noted that the company exceeded earnings expectations, while others expressed concerns about the slower growth in key segments. 

**Analyst Opinions:**
* **FINBOLD:**  Recent analystsâ€™ ratings and price targets for DHR signal a mixed sentiment. While some analysts remain optimistic about the company's future prospects, others are more cautious, citing concerns about the potential impact of macroeconomic headwinds on the company's performance.

**Overall Analysis:**
DHR presents a compelling investment case with a long track record of outperforming the market. The company demonstrates strong financial performance and a focus on innovation. However, the stock is currently facing headwinds, with recent price action suggesting potential weakness. While the expected long-term return remains promising, investors should closely monitor the stock's performance and the broader economic conditions before making any investment decisions. 
